Systematic review, network meta-analysis and economic evaluation of biological therapy for the management of active psoriatic arthritis
An updated economic evaluation was conducted to compare the cost-effectiveness of the four tumour necrosis factor (TNF)-α inhibitors adalimumab, etanercept, golimumab and infliximab in active, progressive psor...